| Gene Set | Leading Edge Genes |
|---|
| WONG EMBRYONIC STEM CELL CORE | HDAC1, DLAT, UBE2G1, NCBP2, ADSL, ANP32E, CKS1B, ATP5O, CCNB2, HADH, UGDH, KIF23, ATP5J, CCT5, CCNC, ZNF22, LSM2 |
| STARK PREFRONTAL CORTEX 22Q11 DELETION DN | RMND5B, ATP5C1, MGST3, PSMA5, PPT1, MRPL40, TPI1, PDGFA, SRP9, ACAT2, ATP5J, UGP2, CCT5, IDH1, COX7A2, OAT, DCTN6, EIF2B4, SNRPD2, PPP2R5C |
| REACTOME REGULATION OF APC ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE | PSMD1, PSMA4, UBE2D1, CDK2, CDC23, PSMA5, CCNB1 |
| PAL PRMT5 TARGETS UP | NNT, CETN2, TMPO, STMN1, NCBP2, FKBP4, ANAPC5, IGBP1, PSIP1, CCNB2, TTK, YWHAB, KIF23, SPCS2, NR2F2, PKD2, TARDBP, EHMT2, LSM2, ERH |
| KEGG PARKINSONS DISEASE | NDUFB3, ATP5O, UBE2G1, ATP5C1, COX6C, VDAC1, ATP5J |
| ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UP | CETN2, PAPSS1, PEA15, NCBP2, MRPL40, NUP133, IGBP1, CKS1B, NDUFB3, MSH6, TOM1L1, PDIA6, ARF3, ZMPSTE24, RPA1, ACLY |
| THEILGAARD NEUTROPHIL AT SKIN WOUND DN | RGS2, MYCBP, PNN, SRP9, ZFP36L2, ME2, HSBP1, HHEX, ZMPSTE24, TOB1, ACLY, OGT, RABIF |
| NUYTTEN EZH2 TARGETS DN | KIF3A, CKS1B, CCNB2, TTK, AUH, CASP6, TMPO, KIF23, HSBP1, FADS1, CCNB1, CENPA, DDHD2, SYPL1, MAP2K6 |
| NCI REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE | UBE2D1, CDK2, CDC23, ANAPC5, CCNB1 |
| NCI AUTODEGRADATION OF CDH1 BY CDH1 APC C | |
| NCI TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL | |
| REACTOME CELL CYCLE MITOTIC | |
| REACTOME CDC20 PHOSPHO APC MEDIATED DEGRADATION OF CYCLIN A | |
| HORIUCHI WTAP TARGETS DN | |
| NCI PHOSPHORYLATION OF THE APC C | UBE2D1, ANAPC5, CCNB1 |
| YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 13 | |
| CORUM F1F0-ATP SYNTHASE EC 3.6.3.14 MITOCHONDRIAL | ATP5O, ATP5I, ATP5C1, ATP5J, ATP5L |
| NCI APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | UBE2D1, CDC23, ANAPC5 |
| NCI APC C CDC20 MEDIATED DEGRADATION OF SECURIN | |
| WONG MITOCHONDRIA GENE MODULE | |
| MARKEY RB1 ACUTE LOF DN | |
| NCI APC CDC20 MEDIATED DEGRADATION OF NEK2A | UBE2D1, CDC23, ANAPC5 |
| CORUM PA28-20S PROTEASOME | |
| NCI CDC20 PHOSPHO APC C MEDIATED DEGRADATION OF CYCLIN A | |
| NCI CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | |
| CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA DN | |
| YU MYC TARGETS UP | |
| REACTOME CHOLESTEROL BIOSYNTHESIS | |
| REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | ATP5O, ATP5I, ATP5C1, ATP5J, ATP5L |
| CHIANG LIVER CANCER SUBCLASS UNANNOTATED DN | |
| MORI LARGE PRE BII LYMPHOCYTE UP | CKS1B, SLBP, CENPA |
| REACTOME INACTIVATION OF APC VIA DIRECT INHIBITION OF THE APCOMPLEX | |
| NCI APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | UBE2D1, ANAPC5, CCNB1 |
| NCI INACTIVATION OF APC C VIA DIRECT INHIBITION OF THE APC C COMPLEX | |
| REACTOME APCDC20 MEDIATED DEGRADATION OF CYCLIN B | UBE2D1, ANAPC5, CCNB1 |
| NCI FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | ATP5O, ATP5I, ATP5C1, ATP5J, ATP5L |
| REACTOME TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL | |
| NCI APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | |
| REACTOME PHOSPHORYLATION OF THE APC | UBE2D1, CCNB1 |